Literature DB >> 20554411

Fatal poisoning due to snorting buprenorphine and alcohol consumption.

Ophélie Ferrant1, Frédérique Papin, Bénédicte Clin, Christian Lacroix, Elodie Saussereau, Jean-Emmanuel Remoué, Jean-Pierre Goullé.   

Abstract

High dosage buprenorphine (Subutex(®)) has been prescribed as a replacement therapy for major opioid dependencies in France since 1996. However, several studies have underlined its lethal risk, especially when administered intravenously, or when combined with benzodiazepines, alcohol or other central nervous system depressants. We report three fatal buprenorphine-related poisonings after snorting, among outside protocol individuals, observed at the Forensic Medicine Unit of Caen University Hospital. Medico-legal autopsies and complementary examinations were performed. The results are presented and discussed. Lethal poisoning after snorting buprenorphine was considered the most probable cause of death. These observations illustrate the risk of fatal poisoning by buprenorphine per-nasal route, which has rarely been reported in the literature although snorting is particularly prized by individuals outside the substitution therapy. We also observed the combination of buprenorphine and alcohol. By evaluating the pharmacological characteristics of this substance, as well as the data previously published in the literature, we have attempted to explain the pathophysiological mechanisms of this particular mode of poisoning that can easily be fatal. Copyright Â
© 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20554411     DOI: 10.1016/j.forsciint.2010.05.015

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  5 in total

1.  Benzodiazepines and alcohol are associated with cases of fatal buprenorphine poisoning.

Authors:  Margareeta Häkkinen; Terhi Launiainen; Erkki Vuori; Ilkka Ojanperä
Journal:  Eur J Clin Pharmacol       Date:  2011-09-17       Impact factor: 2.953

2.  Intranasal buprenorphine alone and in combination with naloxone: Abuse liability and reinforcing efficacy in physically dependent opioid abusers.

Authors:  Sharon L Walsh; Paul A Nuzzo; Shanna Babalonis; Victoria Casselton; Michelle R Lofwall
Journal:  Drug Alcohol Depend       Date:  2016-03-14       Impact factor: 4.492

3.  Clinician beliefs and attitudes about buprenorphine/naloxone diversion.

Authors:  Zev Schuman-Olivier; Hilary Connery; Margaret L Griffin; Steve A Wyatt; Alan A Wartenberg; Jacob Borodovsky; John A Renner; Roger D Weiss
Journal:  Am J Addict       Date:  2013-04-11

4.  Buprenorphine and norbuprenorphine determination in mice plasma and brain by gas chromatography-mass spectrometry.

Authors:  Fouad Chiadmi; Joël Schlatter
Journal:  Anal Chem Insights       Date:  2014-03-10

5.  Fulminant hepatic failure after intravenous injection of sublingual buprenorphine in a patient with hepatitis C.

Authors:  Janine French; Avik Mujumdar; Peter Angus; Paul Gow
Journal:  Clin Case Rep       Date:  2015-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.